Success Metrics

Clinical Success Rate

66.7%

Based on 2 completed trials

Completion Rate

67%(2/3)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Terminated

1(33%)

Phase Distribution

Ph phase_2

33%

Ph not_applicable

67%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution3 total trials

Phase 2Efficacy & side effects

1(33.3%)

N/ANon-phased studies

2(66.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(2)

Terminated(1)

Detailed Status

Completed2

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

66.7%

Most Advanced

Phase 2

Trials by Phase

Phase 21 (33.3%)

N/A2 (66.7%)

Trials by Status

terminated133%

completed267%

Recent Activity

0 active trials

Showing 3 of 3

terminatedphase_2

Cerebrovascular Reactivity Assessed With fNIRS as a Biomarker of TCVI After Acute Traumatic Brain Injury in Military

NCT04058132

completednot_applicable

Pharmacotherapy and Psychotherapy in the Treatment of Erectile Dysfunction

NCT04126252

completednot_applicable

Psychotherapy and Pharmacotherapy in the Treatment of Erectile Dysfunction: A Pilot Study

NCT04179747

Clinical Trials (3)

Showing 3 of 3 trials

NCT04058132Phase 2

Cerebrovascular Reactivity Assessed With fNIRS as a Biomarker of TCVI After Acute Traumatic Brain Injury in Military

Terminated

NCT04126252Not Applicable

Pharmacotherapy and Psychotherapy in the Treatment of Erectile Dysfunction

Completed

NCT04179747Not Applicable

Psychotherapy and Pharmacotherapy in the Treatment of Erectile Dysfunction: A Pilot Study

Completed

All 3 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 3